Catatonia, a state of unresponsiveness characterized by motoric immobility or excessive activity, can be a symptom of various psychiatric disorders. Understanding its causes, manifestations, and treatments is crucial. The Journal of Clinical Psychiatry provides comprehensive insights into catatonia, emphasizing evidence-based diagnostic and therapeutic approaches. Our expert editors ensure that content is clinically relevant and actionable, equipping psychiatrists to recognize and address catatonia effectively.
Catatonia
Recently published articles about Catatonia
Brief Report
Treatment with (Es)ketamine in Catatonia: A Systematic Review of Case Reports
October 13, 2025
Recent evidence suggests that NMDA receptor antagonists, such as ketamine, may offer benefit in catatonia. This systematic review was conducted to evaluate the efficacy and safety of ketamine and...
Recent JCP Articles on Catatonia
Recent PCC Articles on Catatonia
Case Report
Autoimmune Thyroid Disease–Induced Catatonia With Normal Thyroid Function
October 17, 2024
A 26-year-old woman with catatonia and worsening anxiety, insomnia, and alterations in cognition was found to concurrently have autoimmune thyroid disease, but due to an unremarkable initial workup, accurate...
Featured Catatonia Research
Consensus Statement
Next-Step Treatment Options for Treatment-Resistant Depression
January 21, 2026
Strong consensus emerged for augmentation with second-generation antipsychotics, TMS, and ketamine/esketamine in the base vignette. Preferences shifted to include non-augmentative antidepressants and ECT based on patient characteristics.
